BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22738739)

  • 1. Equine herpesvirus-1: what are we still missing?
    Hussey GS
    Vet J; 2012 Aug; 193(2):309-10. PubMed ID: 22738739
    [No Abstract]   [Full Text] [Related]  

  • 2. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants.
    Vandekerckhove AP; Glorieux S; Gryspeerdt AC; Steukers L; Van Doorsselaere J; Osterrieder N; Van de Walle GR; Nauwynck HJ
    Vet Microbiol; 2011 Aug; 152(1-2):21-8. PubMed ID: 21536394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of late viral proteins is restricted in nasal mucosal leucocytes but not in epithelial cells during early-stage equine herpes virus-1 infection.
    Gryspeerdt AC; Vandekerckhove AP; Baghi HB; Van de Walle GR; Nauwynck HJ
    Vet J; 2012 Aug; 193(2):576-8. PubMed ID: 22425309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of latent alpha-herpesviruses in Thoroughbred racing horses.
    Pusterla N; Mapes S; David Wilson W
    Vet J; 2012 Aug; 193(2):579-82. PubMed ID: 22405721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of equine herpesvirus-associated neurological disease: a revised explanation.
    Borchers K; Thein R; Sterner-Kock A
    Equine Vet J; 2006 May; 38(3):283-7. PubMed ID: 16706288
    [No Abstract]   [Full Text] [Related]  

  • 6. The prevalence of latent Equid herpesviruses in the tissues of 40 abattoir horses.
    Edington N; Welch HM; Griffiths L
    Equine Vet J; 1994 Mar; 26(2):140-2. PubMed ID: 8575377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine herpesvirus neurological disease.
    Gilkerson JR; Barrett EJ
    Equine Vet J; 2008 Mar; 40(2):102-3. PubMed ID: 18302993
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
    Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
    Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding.
    Azab W; Zajic L; Osterrieder N
    Vet Res; 2012 Aug; 43(1):61. PubMed ID: 22909178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus).
    Crabb BS; Studdert MJ
    Adv Virus Res; 1995; 45():153-90. PubMed ID: 7793324
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins.
    Azab W; Osterrieder N
    J Virol; 2012 Feb; 86(4):2031-44. PubMed ID: 22171258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model.
    Spiesschaert B; Goldenbogen B; Taferner S; Schade M; Mahmoud M; Klipp E; Osterrieder N; Azab W
    J Virol; 2015 Dec; 89(23):11899-908. PubMed ID: 26378176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
    Osterrieder N; Van de Walle GR
    Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.
    Frampton AR; Goins WF; Cohen JB; von Einem J; Osterrieder N; O'Callaghan DJ; Glorioso JC
    J Virol; 2005 Mar; 79(5):3169-73. PubMed ID: 15709036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine herpesvirus myeloencephalopathy: unravelling the enigma.
    Nugent J; Paillot R
    Vet J; 2009 Jun; 180(3):271-2. PubMed ID: 19141371
    [No Abstract]   [Full Text] [Related]  

  • 16. Third International Havemeyer Workshop on Equine Herpesvirus type 1.
    Kydd JH; Slater J; Osterrieder N; Lunn DP; Antczak DF; Azab W; Balasuriya U; Barnett C; Brosnahan M; Cook C; Damiani A; Elton D; Frampton A; Gilkerson J; Goehring L; Horohov D; Maxwell L; Minke J; Morley P; Nauwynck H; Newton R; Perkins G; Pusterla N; Soboll-Hussey G; Traub-Dargatz J; Townsend H; Van de Walle GR; Wagner B
    Equine Vet J; 2012 Sep; 44(5):513-7. PubMed ID: 22888774
    [No Abstract]   [Full Text] [Related]  

  • 17. Equine herpesvirus 1 and 4.
    Reed SM; Toribio RE
    Vet Clin North Am Equine Pract; 2004 Dec; 20(3):631-42. PubMed ID: 15519823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key Determinants in the Pathogenesis of Equine Herpesvirus 1 and 4 Infections.
    Hussey GS
    Vet Pathol; 2019 Sep; 56(5):656-659. PubMed ID: 31394999
    [No Abstract]   [Full Text] [Related]  

  • 19. Equine herpesviruses 1 and 4: creeping to a solution.
    Smith K
    Vet J; 2005 Jul; 170(1):6-7. PubMed ID: 15914048
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission.
    Spiesschaert B; Osterrieder N; Azab W
    Viruses; 2015 Feb; 7(2):522-42. PubMed ID: 25654240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.